Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprubart in Type 1 Diabetes Mellitus Undergoing Islet Cell Transplantation
NCT06305286Phase 2Active, not recruiting
- Sponsor
- University of Chicago
- Start
- Mar 2024
- Primary completion
- Mar 2029
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tegoprubart in type 1 diabetes mellitus (T1D), sponsored by University of Chicago. Started Mar 2024; status: active, not recruiting.
02
Drugs
tegoprubart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06305286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06305286.